发明名称 Nanopartikler af paclitaxel og albumin i kombination med bevacizumab mod kræft
摘要 The present invention provides combination therapy methods of treating proliferative diseases (such as cancer) comprising a first therapy comprising administering to an individual an effective amount of a taxane in a nanoparticle composition, and a second therapy which may include, for example, radiation, surgery, administration of chemotherapeutic agents (such as an anti-VEGF antibody), or combinations thereof. Also provided are methods of administering to an individual a drug taxane in a nanoparticle composition based on a metronomic dosing regime.
申请公布号 DK2481405(T3) 申请公布日期 2016.06.06
申请号 DK20120154995T 申请日期 2007.11.06
申请人 Abraxis BioScience, LLC 发明人 DESAI, Neil P.;SOON-SHIONG, Patrick
分类号 A61K31/337;A61K9/00;A61K9/51;A61K31/282;A61K31/7072;A61K33/24;A61K39/395;A61K45/06;A61P35/00;A61P35/04 主分类号 A61K31/337
代理机构 代理人
主权项
地址